Pura Vida Investments’s Kite Pharma, Inc. KITE Stock Holding History

Pura Vida Investments’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-49,500	Closed	-$2.77M	–	112
2016 Q3	$2.77M	Buy	49,500 +12,250	+33%	+$683K	0.84%	50
2016 Q2	$1.86M	Hold	37,250	–	–	0.79%	49
2016 Q1	$1.71M	Sell	37,250 -4,200	-10%	-$203K	0.78%	47
2015 Q4	$2.55M	Sell	41,450 -7,300	-15%	-$514K	1.08%	43
2015 Q3	$2.71M	Buy	48,750 +12,750	+35%	+$802K	1.55%	28
2015 Q2	$2.62M	Buy	36,000 +8,350	+30%	+$476K	1.34%	34
2015 Q1	$1.59M	Sell	27,650 -16,600	-38%	-$1.11M	0.82%	43
2014 Q4	$2.55M	Buy	+44,250	New	+$1.86M	0.94%	37

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Pura Vida Investments's KITE Position: Q4 2016 in Review

Pura Vida Investments sold out of Kite Pharma, Inc. (KITE) in Q4 2016, closing a stake of 49,500 shares — an estimated $2.77M sold.

Pura Vida Investments first reported a position in KITE in Q4 2014 and held it in 8 quarters. The position peaked at $2.77M in Q3 2016. 184 funds tracked by Wall St. Rank hold KITE as of Q4 2016.

Pura Vida Investments reported no remaining Kite Pharma, Inc. position as of Q4 2016 after selling out during the quarter.
Pura Vida Investments sold 49,500 Kite Pharma, Inc. shares in Q4 2016, an estimated $2.77M.
Pura Vida Investments first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 8 quarters.
Pura Vida Investments's Kite Pharma, Inc. position peaked at $2.77M in Q3 2016.
184 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2016.

Based on Pura Vida Investments's 13F filing for Q4 2016, filed 14 Feb 2017.